Trial Profile
Phase III trial of VLA 84 in patients with Clostridium infections
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs VLA 84 (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- Sponsors Valneva
- 29 Mar 2016 New trial record